CVS Group Sells Crematoria Operations and Expands in Australia

CVS Group plc ( (GB:CVSG) ) has shared an announcement.

CVS Group plc has finalized the sale of its Crematoria operations to Anima Care UK Limited for £42.4 million, marking a strategic move to streamline its operations. This disposal is expected to result in a one-off profit of £32.0 million in its FY2025 accounts. Concurrently, CVS has expanded its presence in Australia by acquiring VPP Group PTY Ltd, adding six practice sites in Victoria, and now operates 28 practices across 42 sites in the country. These strategic decisions are likely to enhance CVS’s market positioning and operational focus.

The most recent analyst rating on (GB:CVSG) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc shows robust revenue growth and strategic focus on core services, bolstered by positive corporate events. However, challenges like declining profitability, high valuation metrics, and potential overbought technical indicators temper the outlook. These factors result in a moderately positive score, highlighting a balance between growth potential and valuation concerns.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is an AIM-listed provider of veterinary services operating in the UK and Australia. The company focuses on delivering high-quality clinical services with a strong emphasis on its clinical teams and support staff. CVS operates approximately 460 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also runs laboratories and an online retail business. The group employs around 9,000 personnel, including 2,400 veterinary surgeons and 3,300 nurses.

Average Trading Volume: 346,131

Technical Sentiment Signal: Hold

Current Market Cap: £895.3M

See more data about CVSG stock on TipRanks’ Stock Analysis page.